Office Headquarters: (610) 544-3500

perirx log in button

PeriRx Logo


Get News and Updates



CLIA: 39D2085645

PeriRx on Facebook PeriRx on YouTube PeriRx on Google+ Stephen M. Swanick LinkedIn


New York State has a separate and unique regulatory approval process for laboratory diagnostic testing. PeriRx is currently in the application process with our SaliMark™ OSCC test and is vigorously committed to pursuing this application approval. 

How to Read Test Results

This test provides the most accurate molecular information available to stratify the risk for the presence of oral squamous cell carcinoma. A weighted summation of the biomarkers provides a single test score on a continuous scale and can be categorized as low, moderate or high-risk. Low-risk scores are associated with a substantially reduced chance of malignancy. High-risk scores are associated with an increased chance of malignancy while moderate scores carry less additional risk. The exact chance of cancer in any particular patient depends on the test score as well as on other clinical factors. Therefore, the test is intended to be used in the context of a thorough patient evaluation.

What to do After Receiving the Test Results?

  • A low-risk score is associated with a significantly reduced chance that an oral lesion is malignant
  • A moderate-risk score may raise enough concern about an oral lesion to warrant referral to a specialist
  • A high-risk score is associated with a significantly increased chance that an oral lesion is malignant, and referral to a specialist is recommended
  • These results substantially enhance the clinical assessment of patients with oral lesions that are suspicious for cancer